Bronchiectasis from 2012 to 2022.

The previous issue of Clinics in Chest Medicine was published in 2012 and described the state of the art in the disease at that time. In the intervening years, bronchiectasis has experienced something of a renaissance, leaving behind the label of an "orphan disease." Major developments in the past 10 years including a deeper understanding of epidemiology include the development of international registries. An exponential increase in randomized clinical trials in bronchiectasis has strengthened the evidence base for treatments but much work remains to translate the increasing global interest in the disease into a better understanding of the condition and improved patient outcomes.